Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J. vasc. bras ; 20: e20200215, 2021. tab, graf
Artículo en Portugués | LILACS | ID: biblio-1287089

RESUMEN

Resumo Contexto Na insuficiência venosa crônica (IVC), a veia safena parva (VSP) é afetada em 15% dos casos. A cirurgia convencional é a técnica padrão para o tratamento da insuficiência da VSP, sendo a lesão no nervo sural uma complicação bastante temida. O tratamento de termoablação com endolaser tende a ser um método cirúrgico que diminui complicações da terapia cirúrgica da IVC. Objetivos Avaliar os pacientes com IVC submetidos à terapia por endolaser da VSP ao menos 30 dias após o procedimento. Métodos Foram analisados 54 membros inferiores de 46 pacientes submetidos à terapia por endolaser 1470 nm, sob anestesia local, para o tratamento da IVC em um hospital terciário. Os pacientes foram avaliados no período pré-operatório, intraoperatório e pós-operatório de 30 dias, através da clínica, exame físico e achados ecográficos. Resultados Nos 54 membros inferiores submetidos ao tratamento, comparando-se o período pré-operatório e o 30º dia pós-operatório, houve diferença significativa (p < 0,003) na redução do diâmetro da VSP tratada (6,37 mm pré-operatório e 5,15 mm no 30º dia pós-operatório) (IC95% 4,58-5,72) e na melhora do escore de gravidade clínica venosa (VCSS) (média de 8,02 pré-operatório e 6,11 no 30º dia pós-operatório) (IC95% 5,01-7,21) (p < 0,02). Complicações pós-operatórias, como parestesia e flebite, estiveram presentes e foram diagnosticadas em cinco e três pacientes, respectivamente, sem significar alteração na qualidade de vida e nas atividades de rotina. Conclusões A técnica de termoablação com laser da VSP mostrou-se segura e eficaz na redução dos sintomas clínicos e na melhora da qualidade de vida.


Abstract Background The small saphenous vein (SSV) is affected in 15% of chronic venous insufficiency (CVI) cases. Conventional surgery is the standard technique for treatment of SSV insufficiency, but sural nerve injury is a complication of great concern. Endovenous laser ablation is a surgical technique for treatment of CVI that is considered likely to reduce morbidity and mortality. Objectives To evaluate patients with CVI undergoing endovenous laser ablation of the SSV at least 30 days after the procedure. Methods We analyzed 54 lower extremities in 46 patients scheduled for 1470-nm endovenous laser ablation under local anesthesia to treat CVI in a tertiary hospital. Patients were evaluated preoperatively, intraoperatively, and postoperatively over 30 days with clinical examination, physical examination, and ultrasound. Results In the 54 lower extremities treated, there was a significant difference (p < 0.003) in terms of reduction in the diameter of treated veins (6.37 mm preoperatively and 5.15 mm on the 30th postoperative day) and improvement in the venous clinical severity score (VCSS) (means of 8.02 preoperative and 6.11 on the 30th postoperative day) (95%CI, 5.01—7.21) (p < 0.02). Postoperative complications such as paresthesia and phlebitis were present and diagnosed in 5 and 3 patients, respectively, but did not affect their quality of life or routine activities. Conclusions Intravenous laser ablation of the SSV proved to be safe and effective for reducing clinical symptoms and improving quality of life.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Insuficiencia Venosa/cirugía , Procedimientos Endovasculares/efectos adversos , Complicaciones Posoperatorias , Vena Safena , Nervio Sural/lesiones , Enfermedad Crónica , Estudios Retrospectivos , Estudios Longitudinales , Extremidad Inferior , Terapia por Láser/métodos , Anestesia Local
2.
BMC Complement Altern Med ; 13: 274, 2013 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-24499201

RESUMEN

BACKGROUND: Injury to a nerve is the most common reason of acquired peripheral neuropathy. Therefore, searching for effective substance to recover of nerve after injury is need of present era. The current study investigates the protective potential of Standardized Fruit Extract of Punica granatum L (PFE) [Ellagic acid (41.6%), Punicalagins (10%), Granatin (5.1%)] in Tibial & Sural Nerve Transection (TST) induced neuropathic pain in rats. METHODS: TST was performed by sectioning tibial and sural nerve portions of the sciatic nerve and leaving the common peroneal nerve intact. Acetone drop, pin-prick, hot plate, paint brush & Walking Track tests were performed to assess cold allodynia; mechanical heat, hyperalgesia and dynamic mechanical allodynia & tibial functional index respectively. The levels of TNF-α, TBARS, GSH and Nitrite were measured in the sciatic nerve as an index of inflammation & oxidative stress. RESULTS: TST led to significant development of cold allodynia; mechanical and heat hyperalgesia; dynamic mechanical allodynia; functional deficit in walking along with rise in the levels of TBARS, TNF-α, GSH and Nitrite. Administrations of PFE (100 & 300 mg/kg oral), significantly attenuate TST induced behavioral & biochemical changes. Pretreatments of BADGE (120 mg/kg IP) a PPAR-γ antagonist and nitric oxide precursor L-arginine (100 mg/kg IP) abolished the protective effect of PFE. Whereas, pretreatment of L-NAME (5 mg/kg IP) a NOS inhibitor significantly potentiated PFE's protective effect of PFE. CONCLUSION: PFE shown to have attenuating effect in TST induced neuropathic pain which may be attributed to potential PPAR-gamma agonistic activity, nitric oxide inhibitory, anti-inflammatory and anti oxidative actions.


Asunto(s)
Antiinflamatorios/administración & dosificación , Lythraceae/química , Neuralgia/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Nervio Sural/lesiones , Nervio Tibial/lesiones , Animales , Arginina/inmunología , Femenino , Frutas/química , Humanos , Masculino , Neuralgia/genética , Neuralgia/inmunología , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Nervio Sural/efectos de los fármacos , Nervio Tibial/efectos de los fármacos , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología
3.
J Nat Med ; 65(2): 282-92, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21153448

RESUMEN

This study was designed to investigate the therapeutic potential of hydroalcoholic extracts of Acorus calamus (AC) in tibial and sural nerve transection (TST)-induced neuropathic pain in rats. The hot plate, paw heat allodynia, acetone drop, and pinprick tests were performed to assess the degree of heat hyperalgesia, heat and cold allodynia, and mechanical hyperalgesia, respectively, at different time intervals, i.e., day 0, 1, 3, 6, 9, 12, 15, 18, and 21. The tissue superoxide anion and total calcium were measured as markers of oxidative stress. Tissue myeloperoxidase activity was measured as a specific marker of inflammation. Histopathological evaluation was also performed in the nervous tissue to assess the axonal degeneration. Pregabalin served as positive control in this study. TST in rats significantly induced thermal hyperalgesia and allodynia, mechanical hyperalgesia, and increased the levels of superoxide anion, total calcium, and myeloperoxidase (MPO) activity. Moreover significant histological changes were also observed. Oral administration of AC hydroalcoholic extract (100 and 200 mg/kg for 14 days) attenuated TST-induced behavioral, biochemical, and histological changes. Acorus calamus has ameliorative potential in TST-induced painful neuropathy, and this effect may be attributed to its multiple actions including anti-inflammatory, antioxidant, and neuroprotective actions.


Asunto(s)
Acorus/química , Neuralgia/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Nervio Sural/lesiones , Nervio Tibial/lesiones , Animales , Calcio/metabolismo , Modelos Animales de Enfermedad , Femenino , Hiperalgesia , Masculino , Neuralgia/etiología , Neuralgia/metabolismo , Peroxidasa/metabolismo , Extractos Vegetales/química , Ratas , Ratas Wistar , Superóxidos
4.
Neurol Res ; 32 Suppl 1: 96-100, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20034455

RESUMEN

OBJECTIVES: To examine the effects of electroacupuncture stimulation on behavioral changes and neuronal nitric oxide synthase expression in the rat spinal cord after nerve injury. METHODS: Under pentobarbital anesthesia, male Sprague-Dawley rats were subjected to neuropathic surgery by tightly ligating and cutting the left tibial and sural nerves. Behavioral responses to mechanical stimulation were tested for 2 weeks post-operatively. At the end of behavioral testing, electroacupuncture stimulation was applied to ST36 (Choksamni) and SP9 (Eumleungcheon) acupoints. Immunocytochemical staining was performed to investigate changes in the expression of neuronal nitric oxide synthase-immunoreactive neurons in the L4-5 spinal cord. RESULTS: Mechanical allodynia was observed by nerve injury. The mechanical allodynia was decreased after electroacupuncture stimulation. Neuronal nitric oxide synthase expression was also decreased in L4-5 spinal cord by electroacupuncture treatment. DISCUSSION: These results suggest that electroacupuncture relieves mechanical allodynia in the neuropathic rats possibly by the inhibition of neuronal nitric oxide synthase expression in the spinal cord.


Asunto(s)
Electroacupuntura/métodos , Óxido Nítrico Sintasa de Tipo I/metabolismo , Manejo del Dolor , Enfermedades del Sistema Nervioso Periférico/terapia , Médula Espinal/metabolismo , Neuropatía Tibial/terapia , Animales , Inmunohistoquímica , Vértebras Lumbares , Masculino , Neuronas/metabolismo , Óxido Nítrico Sintasa de Tipo I/antagonistas & inhibidores , Dolor/etiología , Dolor/metabolismo , Dimensión del Dolor , Enfermedades del Sistema Nervioso Periférico/metabolismo , Estimulación Física , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Nervio Sural/lesiones , Nervio Tibial/lesiones , Neuropatía Tibial/metabolismo , Factores de Tiempo
5.
Pain ; 139(3): 533-540, 2008 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-18723285

RESUMEN

Sumatriptan and the other triptan drugs target the serotonin receptor subtypes1B, 1D, and 1F (5-HT(1B/D/F)), and are prescribed widely in the treatment of migraine. An anti-migraine action of triptans has been postulated at multiple targets, within the brain and at both the central and peripheral terminals of trigeminal "pain-sensory" fibers. However, as triptan receptors are also located on "pain-sensory" afferents throughout the body, it is surprising that triptans only reduce migraine pain in humans, and experimental cranial pain in animals. Here we tested the hypothesis that sumatriptan can indeed reduce non-cranial, somatic and visceral pain in behavioral models in mice. Because sumatriptan must cross the blood brain barrier to reach somatic afferent terminals in the spinal cord, we compared systemic to direct spinal (intrathecal) sumatriptan. Acute nociceptive thresholds were not altered by sumatriptan pre-treatment, regardless of route. However, in behavioral models of persistent inflammatory pain, we found a profound anti-hyperalgesic action of intrathecal, but not systemic, sumatriptan. By contrast, sumatriptan was completely ineffective in an experimental model of neuropathic pain. The pronounced activity of intrathecal sumatriptan against inflammatory pain in mice raises the possibility that there is a wider spectrum of therapeutic indications for triptans beyond headache.


Asunto(s)
Analgésicos no Narcóticos/uso terapéutico , Dolor/tratamiento farmacológico , Agonistas de Receptores de Serotonina/uso terapéutico , Sumatriptán/uso terapéutico , Ácido Acético/administración & dosificación , Ácido Acético/toxicidad , Analgésicos no Narcóticos/administración & dosificación , Analgésicos no Narcóticos/farmacocinética , Animales , Barrera Hematoencefálica , Carragenina/toxicidad , Evaluación Preclínica de Medicamentos , Formaldehído/toxicidad , Calor/efectos adversos , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/fisiopatología , Inflamación/inducido químicamente , Inflamación/fisiopatología , Inyecciones Intraperitoneales , Inyecciones Espinales , Inyecciones Subcutáneas , Masculino , Ratones , Neuralgia/tratamiento farmacológico , Dolor/fisiopatología , Umbral del Dolor/efectos de los fármacos , Nervio Peroneo/lesiones , Estimulación Física/efectos adversos , Agonistas de Receptores de Serotonina/administración & dosificación , Agonistas de Receptores de Serotonina/farmacocinética , Sumatriptán/administración & dosificación , Sumatriptán/farmacocinética , Nervio Sural/lesiones , Tacto
6.
J Foot Ankle Surg ; 38(3): 185-93, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10384357

RESUMEN

There is a paucity of scientific literature that has reviewed the conservative and surgical treatment efficacy for the management of injuries causing neurapraxia and axonotmesis. This retrospective study evaluates the clinical outcomes of certain treatments for these injuries. Twenty-seven patients fulfilled the inclusion/exclusion criteria for the study, and represented both genders and a wide variety of ages, weights, levels of education, and backgrounds. Surgical intervention resulted in a slightly better clinical outcome when compared to conservative therapies. Patients undergoing surgery for a single nerve problem improved more than those who underwent surgery when three or more nerves were involved. Failure was most often associated with: 1) multiple nerve injuries, 2) a previous history of psychopathology, and 3) application of conservative therapy without surgical intervention for single nerve injury.


Asunto(s)
Enfermedades del Sistema Nervioso Periférico/terapia , Nervio Peroneo/lesiones , Nervio Sural/lesiones , Administración Tópica , Adolescente , Adulto , Anciano , Traumatismos del Tobillo/etiología , Traumatismos del Tobillo/terapia , Capsaicina/administración & dosificación , Niño , Femenino , Traumatismos de los Pies/etiología , Traumatismos de los Pies/terapia , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA